Renin–angiotensin system inhibitors and mortality in patients with COVID-19

Association of renin–angiotensin system inhibitors with risk of death in patients with hypertension (HTN) and coronavirus disease 2019 (COVID-19) is not well characterized. The aim of this study was to evaluate the outcomes of patients with HTN and COVID-19 with respect to different chronic antihype...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Luca, Malagoli, Alessandro, Biagi, Andrea, Zanni, Alessia, Sticozzi, Concetta, Comastri, Greta, Pannone, Luigi, Gandolfi, Stefano, Vergara, Pasquale, Villani, Giovanni Quinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680554/
https://www.ncbi.nlm.nih.gov/pubmed/33222020
http://dx.doi.org/10.1007/s15010-020-01550-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680554/
https://www.ncbi.nlm.nih.gov/pubmed/33222020
http://dx.doi.org/10.1007/s15010-020-01550-0

Ejemplares similares